Study on the Role of Probiotics in Pulmonary Inflammatory Response and Immune Function in COPD Patients
Abstract
paper is to systematically investigate the effects of probiotics on pulmonary inflammatory response and immune function in COPD patients,
their mechanisms for improving pulmonary inflammation and immune imbalance in COPD, and to explore the potential of their clinical application, with a view to providing a new strategy for the adjuvant treatment of COPD.
Keywords
Full Text:
PDFReferences
[1] Rodrigues S O, Cunha C, Soares G M V, et al. Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease [J]. Pharmaceuticals (Basel), 2021, 14(10).
[3] Karakasidis E, Kotsiou O S, Gourgoulianis K I. Lung and Gut Microbiome in COPD [J]. J Pers Med, 2023, 13(5).
[4] Chunxi L, Haiyue L, Yanxia L, et al. The Gut Microbiota and Respiratory Diseases: New Evidence [J]. J Immunol Res, 2020, 2020:
2340670.
[5] Budden K F, Gellatly S L, Wood D L, et al. Emerging pathogenic links between microbiota and the gut-lung axis [J]. Nat Rev Microbiol,
2017, 15(1): 55-63.
[6] Vutcovici M, Brassard P, Bitton A. Inflammatory bowel disease and airway diseases [J]. World J Gastroenterol, 2016, 22(34): 7735-41.
[7] Keely S, Talley N J, Hansbro P M. Pulmonary-intestinal cross-talk in mucosal inflammatory disease [J]. Mucosal Immunol, 2012, 5(1):
7-18.
[8] Qu L, Cheng Q, Wang Y, et al. COPD and Gut-Lung Axis: How Microbiota and Host Inflammasome Influence COPD and Related Ther-
apeutics [J]. Front Microbiol, 2022, 13: 868086.
[9] Wang L, Cai Y, Garssen J, et al. The Bidirectional Gut-Lung Axis in Chronic Obstructive Pulmonary Disease [J]. Am J Respir Crit Care
Med, 2023, 207(9): 1145-60.
[10] Li H, Liu Q, Jiang Y, et al. Disruption of th17/treg balance in the sputum of patients with chronic obstructive pulmonary disease [J]. Am
J Med Sci, 2015, 349(5): 392-7.
[11] Wiertsema S P, van Bergenhenegouwen J, Garssen J, et al. The Interplay between the Gut Microbiome and the Immune System in the
Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies [J]. Nutrients, 2021, 13(3).
[12] Madden J A, Hunter J O. A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics [J]. Br J
Nutr, 2002, 88 Suppl 1: S67-72.
[13] Snchez B, Urdaci M C, Margolles A. Extracellular proteins secreted by probiotic bacteria as mediators of effects that promote mucosabacteria interactions [J]. Microbiology (Reading), 2010, 156(Pt 11): 3232-42.
[14] Rahman M M, Siddique N, Gilman M A A, et al. Genomic and In Vitro Analysis of Pediococcus pentosaceus MBBL4 Implicated Its
Therapeutic Use Against Mastitis Pathogens and as a Potential Probiotic [J]. Probiotics and Antimicrobial Proteins, 2025: 1-19.
[15] Mazziotta C, Tognon M, Martini F, et al. Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health [J].
Cells, 2023, 12(1).
[16] Melali H, Abdolahi A, Sheikhbahaei E, et al. Impact of Probiotics on Gastrointestinal Function and Metabolic Status After Roux-en-Y
Gastric Bypass: A Double-Blind, Randomized Trial [J]. Obes Surg, 2024, 34(6): 2033-41.
[17] Wu Y, Jha R, Li A, et al. Probiotics (Lactobacillus plantarum HNU082) Supplementation Relieves Ulcerative Colitis by Affecting Intestinal Barrier Functions, Immunity-Related Gene Expression, Gut Microbiota, and Metabolic Pathways in Mice [J]. Microbiol Spectr,
2022, 10(6): e0165122.
[18] Natalini J G, Singh S, Segal L N. The dynamic lung microbiome in health and disease [J]. Nat Rev Microbiol, 2023, 21(4): 222-35.
[19] Jiang M, Wang J, Li Z, et al. Dietary Fiber-Derived Microbial Butyrate Suppresses ILC2-Dependent Airway Inflammation in COPD [J].
Mediators Inflamm, 2024, 2024: 6263447.
[20] Carvalho J L, Miranda M, Fialho A K, et al. Oral feeding with probiotic Lactobacillus rhamnosus attenuates cigarette smoke-induced
COPD in C57Bl/6 mice: Relevance to inflammatory markers in human bronchial epithelial cells [J]. PLoS One, 2020, 15(4): e0225560.
[21] Van den Abbeele P, Belzer C, Goossens M, et al. Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an
in vitro gut model [J]. Isme j, 2013, 7(5): 949-61.
[22] Duan K I, Donovan L M, Spece L J, et al. Trends and Rural-Urban Differences in the Initial Prescription of Low-Value Inhaled Corticosteroids among U.S. Veterans with Chronic Obstructive Pulmonary Disease [J]. Ann Am Thorac Soc, 2023, 20(5): 668-76.
[23] Zhang E, Ma Z, Lu M. Contribution of T- and B-cell intrinsic toll-like receptors to the adaptive immune response in viral infectious diseases [J]. Cell Mol Life Sci, 2022, 79(11): 547.
[24] Rastogi S, Singh A. Gut microbiome and human health: Exploring how the probiotic genus Lactobacillus modulate immune responses [J].
Front Pharmacol, 2022, 13: 1042189.
[25] Yan J, Huang C, Jiang D, et al. Macrophage Polarization and Its Impact on Osteoporosis [J]. Results Probl Cell Differ, 2024, 74: 291-6.
[26] Schwarz A, Philippsen R, Piticchio S G, et al. Crosstalk between microbiome, regulatory T cells and HCA2 orchestrates the inflammatory response in a murine psoriasis model [J]. Front Immunol, 2023, 14: 1038689.
[27] Eapen M S, Hansbro P M, McAlinden K, et al. Abnormal M1/M2 macrophage phenotype profiles in the small airway wall and lumen in
smokers and chronic obstructive pulmonary disease (COPD) [J]. Sci Rep, 2017, 7(1): 13392.
[28] Cervilha D A B, Ito J T, Loureno J D, et al. The Th17/Treg Cytokine Imbalance in Chronic Obstructive Pulmonary Disease Exacerbation in an Animal Model of Cigarette Smoke Exposure and Lipopolysaccharide Challenge Association [J]. Sci Rep, 2019, 9(1): 1921.
[29] Sales D S, Ito J T, Zanchetta I A, et al. Regulatory T-Cell Distribution within Lung Compartments in COPD [J]. Copd, 2017, 14(5):
533-42.
[30] Zheng X, Zhang L, Chen J, et al. Dendritic cells and Th17/Treg ratio play critical roles in pathogenic process of chronic obstructive pulmonary disease [J]. Biomed Pharmacother, 2018, 108: 1141-51.
[31] Karimi K, Inman M D, Bienenstock J, et al. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response
in mice [J]. Am J Respir Crit Care Med, 2009, 179(3): 186-93.
[32] Feleszko W, Jaworska J, Rha R D, et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated
with an increase of T regulatory-dependent mechanisms in a murine model of asthma [J]. Clin Exp Allergy, 2007, 37(4): 498-505.
[33] Koh A, De Vadder F, Kovatcheva-Datchary P, et al. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial
Metabolites [J]. Cell, 2016, 165(6): 1332-45.
[34] Livingston M, Loach D, Wilson M, et al. Gut commensal Lactobacillus reuteri 100-23 stimulates an immunoregulatory response [J]. Immunol Cell Biol, 2010, 88(1): 99-102.
[35] Liu P, Hu T, Kang C, et al. Research Advances in the Treatment of Allergic Rhinitis by Probiotics [J]. J Asthma Allergy, 2022, 15:
1413-28.
[36] Singh T P, Natraj B H. Next-generation probiotics: a promising approach towards designing personalized medicine [J]. Crit Rev Microbiol, 2021, 47(4): 479-98.
[37] Ladjemi M Z, Lecocq M, Weynand B, et al. Increased IgA production by B-cells in COPD via lung epithelial interleukin-6 and TACI
pathways [J]. Eur Respir J, 2015, 45(4): 980-93.
[38] Bertrand Y, Snchez-Montalvo A, Hox V, et al. IgA-producing B cells in lung homeostasis and disease [J]. Front Immunol, 2023, 14:
1117749.
[39] Su Z, Ma C, Ru X, et al. Effects of probiotic treatment on patients and animals with chronic obstructive pulmonary disease: a systematic
review and meta-analysis of randomized control trials [J]. Front Cell Infect Microbiol, 2024, 14: 1411222.
[40] Burrows K, Ngai L, Chiaranunt P, et al. A gut commensal protozoan determines respiratory disease outcomes by shaping pulmonary immunity [J]. Cell, 2025, 188(2): 316-30.e12.
DOI: http://dx.doi.org/10.70711/mhr.v2i6.6854
Refbacks
- There are currently no refbacks.
